International Headache Society global practice recommendations for the acute pharmacological treatment of migraine-Reference-Cited by-同舟云学术

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

Published:2024-08 Issue:8 Volume:44 Page:
ISSN:0333-1024
Container-title:Cephalalgia
language:en
Short-container-title:Cephalalgia

Author:

Puledda Francesca¹^ORCID,Sacco Simona²,Diener Hans-Christoph³^ORCID,Ashina Messoud⁴⁵,Al-Khazali Haidar M.⁴,Ashina Sait⁵⁶^ORCID,Burstein Rami⁷,Liebler Eric⁸,Cipriani Andrea⁹¹⁰¹¹,Chu Min Kyung¹²^ORCID,Cocores Alexandra¹³,Dodd-Glover Freda¹⁴,Ekizoğlu Esme¹⁵,Garcia-Azorin David¹⁶^ORCID,Göbel Carl¹⁷¹⁸,Goicochea Maria Teresa¹⁹,Hassan Amr²⁰,Hirata Koichi²¹,Hoffmann Jan¹^ORCID,Jenkins Bronwyn²²,Kamm Katharina²³^ORCID,Lee Mi Ji²⁴^ORCID,Ling Yu-Hsiang²⁵²⁶^ORCID,Lisicki Marco²⁶,Martinelli Daniele²⁷^ORCID,Monteith Teshamae S.¹³^ORCID,Ornello Raffaele²^ORCID,Ozge Aynur²⁸,Peres Mario²⁹^ORCID,Pozo-Rosich Patricia³⁰^ORCID,Romanenko Volodymyr³¹,Schwedt Todd J.³²,Souza Marcio Nattan P.³³^ORCID,Takizawa Tsubasa³⁴,Terwindt Gisela M.³⁵,Thuraiaiyah Janu⁴^ORCID,Togha Mansoureh³⁶³⁷^ORCID,Vandenbussche Nicolas³⁸³⁹,Wang Shuu-Jiun²⁵⁴⁰⁴¹^ORCID,Yu Shengyuan⁴²^ORCID,Tassorelli Cristina²⁷⁴³^ORCID

Affiliation:

1. Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK

2. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

3. Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany

4. Department of Neurology, Danish Headache Center, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

6. Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, USA

7. Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA

8. International Headache Society, London, UK

9. Department of Psychiatry, University of Oxford, Oxford, UK

10. Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK

11. Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK

12. Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

13. Department of Neurology - Headache Division, University of Miami, Miller School of Medicine, Miami, USA

14. Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana

15. Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

16. Headache Unit, Department of Neurology, Hospital Clinico Universitario de Valladolid, Valladolid, Spain

17. Kiel Migraine and Headache Centre, Kiel, Germany

18. Department of Neurology, Christian-Albrechts University, Kiel, Germany

19. Neurology Department, Headache Clinic, Fleni, Buenos Aires, Argentina

20. Department of Neurology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt

21. Neurology, Dokkyo Medical University, Mibu, Tochigi, Japan

22. Royal North Shore Hospital, St Leonards, Sydney, Australia

23. Department of Neurology, Klinikum der Universitat Munchen, Munich, Germany

24. Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea

25. Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

26. Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Córdoba, Córdoba, Argentina

27. IRCCS Mondino Foundation, Headache Science Center, Pavia, Italy

28. Mersin University School of Medicine, Mersin, Turkey

29. Institute of Psychiatry, HCFMUSP, Sao Paulo, Brazil

30. Headache Unit, Neurology Department, Hospital Universitari Vall d’Hebron and Headache & Neurological Pain Research Group, Vall d’Hebron Institute of Research, Barcelona, Spain

31. Vita Medical Center, Kyiv, Ukraine

32. Department of Neurology, Mayo Clinic, Phoenix, AZ, USA

33. Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil

34. Department of Neurology, Keio University School of Medicine, Tokyo, Japan

35. Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands

36. Neurology ward, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

37. Headache department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

38. Department of Neurology, Ghent University Hospital, Ghent, Belgium

39. Department of Neurology, AZ Sint-Jan Brugge, Bruges, Belgium

40. College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

41. Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

42. Department of Neurology, Chinese PLA General Hospital, Beijing, China

43. Department of Brain and Behavioral Science, University of Pavia, Pavia, Italy

Abstract

Background In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to provide treatment options for all possible settings, including those with limited access to migraine medications. Methods An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group. Results A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained. Conclusion Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/03331024241252666

Reference308 articles.

1. World Health Organization. World Health Organization Model List of Essential Medicines, https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02. (2023, accessed 8 January 2024).

2. Digital mental health: challenges and next steps

3. Triptans (Serotonin, 5-HT1B/1DAgonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials

4. Subcutaneous sumatriptan during the migraine aura

5. No effect of eletriptan administration during the aura phase of migraine